Nifty
:
25683.30
Sensex
:
83576.24
-193.55 (-0.75%)
-604.72 (-0.72%)
Nifty
Sensex
:
:
25683.30
83576.24
-193.55 (-0.75%)
-604.72 (-0.72%)

Sotac Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
64/99

BSE: Not Listed | NSE: SOTAC

NSE BSE
112.10
09-Jan-2026
  • Open
  • High
  • Low
  • Previous Close
  •  112.1
  •  112.1
  •  112.1
  •  117.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1200
  •  134520
  •  152.35
  •  88.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 123.87
  • 15.43
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 166.01
  • 0.09%
  • 2.33

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.85%
  • 5.50%
  • 5.12%
  • FII
  • DII
  • Others
  • 16.14%
  • 0.00%
  • 0.39%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 44.14

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 17.30

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
-
96.99
103.83
77.48
73.15
Net Sales Growth
-
-6.59%
34.01%
5.92%
 
Cost Of Goods Sold
-
68.31
79.61
57.27
56.06
Gross Profit
-
28.68
24.22
20.21
17.10
GP Margin
-
29.57%
23.33%
26.08%
23.38%
Total Expenditure
-
83.35
95.51
70.17
66.98
Power & Fuel Cost
-
1.21
1.29
1.00
0.78
% Of Sales
-
1.25%
1.24%
1.29%
1.07%
Employee Cost
-
1.61
2.05
2.58
2.24
% Of Sales
-
1.66%
1.97%
3.33%
3.06%
Manufacturing Exp.
-
6.18
6.79
4.16
4.28
% Of Sales
-
6.37%
6.54%
5.37%
5.85%
General & Admin Exp.
-
4.13
4.42
3.81
1.47
% Of Sales
-
4.26%
4.26%
4.92%
2.01%
Selling & Distn. Exp.
-
1.66
0.86
0.99
0.27
% Of Sales
-
1.71%
0.83%
1.28%
0.37%
Miscellaneous Exp.
-
0.24
0.50
0.36
1.89
% Of Sales
-
0.25%
0.48%
0.46%
2.58%
EBITDA
-
13.64
8.32
7.31
6.17
EBITDA Margin
-
14.06%
8.01%
9.43%
8.43%
Other Income
-
3.90
0.49
0.35
0.22
Interest
-
2.58
1.74
2.04
0.57
Depreciation
-
3.84
3.10
2.28
1.13
PBT
-
11.12
3.96
3.35
4.69
Tax
-
1.84
0.38
1.64
1.82
Tax Rate
-
16.55%
9.60%
41.73%
38.81%
PAT
-
8.03
4.28
2.88
2.88
PAT before Minority Interest
-
9.28
3.58
2.29
2.88
Minority Interest
-
-1.25
0.70
0.59
0.00
PAT Margin
-
8.28%
4.12%
3.72%
3.94%
PAT Growth
-
87.62%
48.61%
0.00%
 
EPS
-
7.30
3.89
2.62
2.62

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
53.25
45.26
19.46
6.62
Share Capital
11.05
11.05
8.05
2.30
Total Reserves
42.20
34.21
1.94
4.32
Non-Current Liabilities
13.06
10.84
8.14
1.01
Secured Loans
4.14
10.76
7.64
0.97
Unsecured Loans
10.05
1.37
0.13
0.00
Long Term Provisions
0.16
0.14
0.10
0.06
Current Liabilities
51.55
43.73
45.81
27.61
Trade Payables
18.94
28.89
25.39
19.74
Other Current Liabilities
12.32
4.18
7.53
1.50
Short Term Borrowings
18.75
9.88
10.82
5.19
Short Term Provisions
1.54
0.78
2.06
1.18
Total Liabilities
123.03
103.90
73.64
35.24
Net Block
48.69
35.51
25.92
8.80
Gross Block
62.59
45.60
32.91
13.55
Accumulated Depreciation
13.90
10.09
6.99
4.75
Non Current Assets
53.20
43.25
26.50
9.36
Capital Work in Progress
0.20
5.12
0.04
0.00
Non Current Investment
3.78
2.10
0.00
0.39
Long Term Loans & Adv.
0.52
0.53
0.54
0.17
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
69.83
60.65
47.14
25.88
Current Investments
0.00
0.00
0.00
0.00
Inventories
20.26
18.01
13.64
5.39
Sundry Debtors
34.11
26.29
14.74
12.25
Cash & Bank
1.56
3.42
9.68
0.03
Other Current Assets
13.90
0.14
0.73
0.07
Short Term Loans & Adv.
13.68
12.79
8.34
8.13
Net Current Assets
18.28
16.92
1.33
-1.73
Total Assets
123.03
103.90
73.64
35.24

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
-4.33
-16.08
8.14
6.35
PBT
11.12
3.96
3.93
4.69
Adjustment
6.26
2.36
4.33
3.43
Changes in Working Capital
-20.91
-20.71
1.57
0.08
Cash after chg. in Working capital
-3.53
-14.38
9.83
8.21
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-0.80
-1.69
-1.68
-1.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.62
-19.68
-11.67
-3.52
Net Fixed Assets
-1.59
-6.10
-6.96
Net Investments
-1.83
-7.50
-4.00
Others
-10.20
-6.08
-0.71
Cash from Financing Activity
16.09
29.49
13.14
-2.83
Net Cash Inflow / Outflow
-1.85
-6.26
9.61
0.00
Opening Cash & Equivalents
3.42
9.68
0.08
0.02
Closing Cash & Equivalent
1.56
3.42
9.68
0.03

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
48.19
40.96
12.41
8.23
ROA
8.17%
4.03%
4.20%
8.23%
ROE
18.83%
12.96%
27.53%
63.16%
ROCE
16.40%
10.22%
21.50%
31.31%
Fixed Asset Turnover
1.79
2.65
3.34
4.12
Receivable days
113.65
72.11
63.58
45.25
Inventory Days
72.01
55.63
44.84
25.51
Payable days
127.81
124.45
143.83
106.65
Cash Conversion Cycle
57.86
3.30
-35.41
-35.90
Total Debt/Equity
0.82
0.55
2.21
1.12
Interest Cover
5.31
3.28
2.92
9.24

Annual Reports:

FY 2025
FY 2024
FY 2023

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.